US Patent Issued to PFIZER on June 2 for "Pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-ylcarbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyljurea" (British Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,803, issued on June 2, was assigned to PFIZER INC. (New York).

"Pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-ylcarbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyljurea" was invented by James Joseph Hussey (Sandwich, Great Britain) and Andrew Gilbert Bright (Winchester, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable alkanesulphonate salt thereof, that is a cl...